Mintz Levin (on Behalf of Fulgent Genetics, INC.)

Healthcare

Based in CA

🤖

AI Overview

With $0 in lobbying spend across 9 quarterly filings, Mintz Levin (on Behalf of Fulgent Genetics, INC.) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2025.

$0
Total Spend
3
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$0
2024$0
2025$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

  • Fulgent: Uninsured Program Fund (Pub. L. 116-136, Pub. L. 116-260)
  • Uninsured Program Fund (Pub. L. 116-136, Pub. L. 116-260)
  • Site-neutral payment policy proposals, including the Lower Costs, More Transparency Act (H.R. 5378), Telehealth Modernization Act of 2023 (H.R. 7623), Medicaid Disproportionate Share Hospital Cuts, in
  • The Telehealth Modernization Act of 2024 (H.R. 7623) and the Preserving Telehealth, Hospital, and Ambulance Access Act (H.R. 8261); The Health Care Cybersecurity Improvement Act of 2024 (S. 4054); Bip

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.